EpiVax Joins Intravacc, CEPI on Project to Develop Universal Betacoronavirus Vaccine
- Written by PR Newswire
![]() |
PROVIDENCE, R.I., Oct. 31, 2022 /PRNewswire/ -- EpiVax, Inc. ("EpiVax") is pleased to announce participation in a new project with Intravacc, funded by CEPI (Coalition for Epidemic Preparedness Innovations), to develop universal vaccines for betacoronaviruses, including SARS-CoV-2. EpiVax will be carrying out the vaccine epitope selection...
Read more: EpiVax Joins Intravacc, CEPI on Project to Develop Universal Betacoronavirus Vaccine















